— Know what they know.
Not Investment Advice

LALPATHLAB.BO

Dr. Lal PathLabs Limited
1W: +0.3% 1M: -7.8% 3M: -58.4% YTD: -9.6% 1Y: -53.0% 3Y: -31.8% 5Y: -41.7%
₹1,329.30 ($14.33)
+9.35 (+0.71%)
 
Weekly Expected Move ±3.5%
₹1230 ₹1277 ₹1324 ₹1371 ₹1418
BSE · Healthcare · Medical - Diagnostics & Research · ₹222.0B · Alpha Radar Sell · Power 29
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹222.0B ($2.4B)
52W Range1202.725-1771.3
Volume8,588
Avg Volume11,073
Beta0.04
Dividend₹12.65
Analyst Ratings
No analyst coverage
Company Info
CEOShankha Banerjee
Employees4,099
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2015-12-23
Tower B, SAS Tower
Gurugram 122001
IN
91 12 4301 6500
About Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms